Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases

[1] Fudenberg HH(1970)Classification of the primary immune deficiencies: Who Recommendation N Engl J Med 283 656-670

[2] Good RA(1968)Immunological reconstitution of sex-linked lymphopenic immunological deficiency Lancet 2 1366-1369

[3] Hitzig W(2003)Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 Lancet 361 553-560

[4] Kunkel HG(2006)Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team Bone Marrow Transplant 37 469-477

[5] Roitt IM(2005)Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen Blood 105 879-885

[6] Rosen FS(2005)Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning Bone Marrow Transplant 35 S45-S47

[7] Rowe DS(2013)B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID Int J Hematol 98 355-360

[8] Seligmann M(2011)Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID Bone Marrow Transplant 46 1526-1531

[9] Soothill JR(2018)Population pharmacokinetics of intravenous busulfan in Japanese pediatric patients with primary immunodeficiency diseases J Clin Pharmacol 58 327-331

[10] Gatti RA(2014)Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency Clin Infect Dis 59 545-548

[1] Fudenberg HH(1970)Classification of the primary immune deficiencies: Who Recommendation N Engl J Med 283 656-670

[2] Good RA(1968)Immunological reconstitution of sex-linked lymphopenic immunological deficiency Lancet 2 1366-1369

[3] Hitzig W(2003)Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 Lancet 361 553-560

[4] Kunkel HG(2006)Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team Bone Marrow Transplant 37 469-477

[5] Roitt IM(2005)Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen Blood 105 879-885

[6] Rosen FS(2005)Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning Bone Marrow Transplant 35 S45-S47

[7] Rowe DS(2013)B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID Int J Hematol 98 355-360

[8] Seligmann M(2011)Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID Bone Marrow Transplant 46 1526-1531

[9] Soothill JR(2018)Population pharmacokinetics of intravenous busulfan in Japanese pediatric patients with primary immunodeficiency diseases J Clin Pharmacol 58 327-331

[10] Gatti RA(2014)Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency Clin Infect Dis 59 545-548